Sardona Therapeutics, winner of the Servier Spark Award

Servier and MBC Biolabs awarded the Servier Spark Award* June 2021 to Sardona Therapeutics, a biotech that develops small molecules blocking the interaction between an RNA-binding protein and its target RNAs. This award will allow Sardona Therapeutics to continue developing its preclinical program in oncology, in indications such as triple negative breast cancer.

Learn more

‍